Potential of pulsed light technology for control of SARS-CoV-2 in hospital environments

被引:9
|
作者
Jean, Julie [1 ]
Rodriguez-Lopez, Maria Isabel [2 ]
Jubinville, Eric [1 ]
Nunez-Delicado, Estrella [2 ]
Gomez-Lopez, Vicente M. [3 ]
机构
[1] Univ Laval, Fac Sci Agr & Alimentat, Dept Sci Aliments, Quebec City, PQ, Canada
[2] Univ Catolica San Antonio Murcia, Dept Tecnol Alimentac & Nutr, Campus Jeronimos, E-30107 Murcia, Spain
[3] Univ Catolica San Antonio Murcia, Catedra Alimentos Salud, Campus Jeronimos, E-30107 Murcia, Spain
关键词
SARS-CoV-2; COVID-19; Pulsed light; Disinfection; Hospital-acquired infections; Touching surfaces; XENON ULTRAVIOLET-LIGHT; DISINFECTION SYSTEM; VIRUS INACTIVATION; FELINE CALICIVIRUS; ENTERIC VIRUSES; UV-IRRADIATION; CORONAVIRUS; INFECTION; SURFACES; SURVIVAL;
D O I
10.1016/j.jphotobiol.2020.112106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The emergence of the SARS-CoV-2 infection and its potential transmission through touching surfaces in clinical environments have impelled the use of conventional and novel methods of disinfection to prevent its spreading. Among the latter, pulsed light may be an effective, non-chemical decontamination alternative. Pulsed light technology inactivates microorganisms and viruses by using high intensity polychromatic light pulses, which degrades nucleic acids and proteins. This review describes this technology, compiles and critically analyzes the evidence about the virucidal efficacy of pulsed light technology with view on its potential use against SARS-CoV-2 in touching surfaces in health-care facilities. The efficacy of pulsed light proved against many different kind of viruses allows to conclude that is a suitable candidate to inactivate SARS-CoV-2 as long as the required fluence is applied and the appropriated exposure to contaminated surfaces is guaranteed.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] On airborne transmission and control of SARS-Cov-2
    Yao, Maosheng
    Zhang, Lu
    Ma, Jianxin
    Zhou, Lian
    SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 731
  • [32] Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa
    Kufa, Tendesayi
    Jassat, Waasila
    Cohen, Cheryl
    Tempia, Stefano
    Masha, Maureen
    Wolter, Nicole
    Walaza, Sibongile
    Gottburg, Anne
    Govender, Nelesh P.
    Hunt, Gillian
    Shonhiwa, Andronica Moipone
    Ebonwu, Joy
    Ntshoe, Genevie
    Maruma, Wellington
    Bapela, Poncho
    Ndhlovu, Nomathamsanqa
    Mathema, Hlengani
    Modise, Motshabi
    Shuping, Liliwe
    Manana, Pinky N.
    Moore, David
    Dangor, Ziyaad
    Verwey, Charl
    Madhi, Shabir A.
    Saloojee, Haroon
    Zar, Heather J.
    Blumberg, Lucille
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (01) : 34 - 47
  • [33] Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
    Jeremiah, Sundararaj Stanleyraj
    Miyakawa, Kei
    Ryo, Akihide
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, 14 (04)
  • [34] Nanomaterials and Biosensing Technology for the SARS-CoV-2 Detection
    Li Yanyan
    Peng Yusi
    Lin Chenglong
    Luo Xiaoying
    Teng Zheng
    Zhang Xi
    Huang Zhengren
    Yang Yong
    JOURNAL OF INORGANIC MATERIALS, 2023, 38 (01) : 3 - 31
  • [35] Decay of infectious SARS-CoV-2 and surrogates in aquatic environments
    Sala-Comorera, Laura
    Reynolds, Liam J.
    Martin, Niamh A.
    O'Sullivan, John J.
    Meijer, Wim G.
    Fletcher, Nicola F.
    WATER RESEARCH, 2021, 201
  • [36] Preventing SARS-CoV-2 transmission in rehabilitation and water environments
    Romano-Bertrand, S.
    Glele, L-S Aho
    Grandbastien, B.
    Lepelletier, D.
    JOURNAL OF HOSPITAL INFECTION, 2020, 105 (04) : 625 - 627
  • [37] Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
    Nicholas E. Ingraham
    David Boulware
    Matthew A. Sparks
    Timothy Schacker
    Bradley Benson
    Jeffrey A. Sparks
    Thomas Murray
    John Connett
    Jeffrey G. Chipman
    Anthony Charles
    Christopher J. Tignanelli
    Critical Care, 24
  • [38] Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
    Ingraham, Nicholas E.
    Boulware, David
    Sparks, Matthew A.
    Schacker, Timothy
    Benson, Bradley
    Sparks, Jeffrey A.
    Murray, Thomas
    Connett, John
    Chipman, Jeffrey G.
    Charles, Anthony
    Tignanelli, Christopher J.
    CRITICAL CARE, 2020, 24 (01)
  • [39] Size distribution and relationship of airborne SARS-CoV-2 RNA to indoor aerosol in hospital ward environments
    V. Groma
    Sz. Kugler
    Á. Farkas
    P. Füri
    B. Madas
    A. Nagy
    T. Erdélyi
    A. Horváth
    V. Müller
    R. Szántó-Egész
    A. Micsinai
    G. Gálffy
    J. Osán
    Scientific Reports, 13
  • [40] Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2
    Oleinik, L. A.
    Madonov, P. G.
    Pykhtina, M. B.
    MOLECULAR BIOLOGY, 2023, 57 (02) : 291 - 298